MOORE JOHN R
SEC insider (Form 3/4/5 filer). CIK 0001191702. General Counsel at Edgewise Therapeutics, Inc. (EWTX). 19 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOULDER, CO.
Companies MOORE JOHN R has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Officer, General Counsel
MOORE JOHN R
CIK: 0001191702
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edgewise Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect6.7K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.4K shares at avg. $43.81$107K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect59 shares at avg. $44.41$3K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect99 shares at avg. $44.50$4K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.4K shares at avg. $43.80$106K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect5.8K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
32.5K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
161.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 6,718 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,439 | $43.81 | $106,848 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 59 | $44.41 | $2,620 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 99 | $44.50 | $4,406 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,419 | $43.80 | $105,949 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 5,781 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 32,500 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 161,250 | - | - | Direct |
1-10 of 19 transactions